Thenyldiamine
- Level
- Commodity
- Parent
- 51313400
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51313414This classification denotes a histamine-1 receptor antagonist with the molecular formula C14H19N3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier E4U52363JE, chemically known as 1,2-ethanediamine, n,n-dimethyl-n-2-pyridinyl-n-(3-thienylmethyl)- but generally known as thenyldiamine, which bears US NIH Compound Identifier 7066. European Medicines Agency schedules Thenyldiamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10962MIG. The term THENYLDIAMINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 31, No10, 1977, List 17). THENYLDIAMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule thenyldiamine under HS 29349990 and SITC 51579. As of Q4 2014, THENYLDIAMINE remains the US FDA Preferred Term for this commodity. Thenyldiamine bears US NLM identifiers UMLS ID C0076383 and NCI Concept Code C84200. SMILES: S1CC(CN(CCN(C)C)C2NCCCC2)CC1.
Same parent
Under 51313400 · 41Activities that produce or sell this
KBLI · 9Inherited from family 51310000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.